Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis

BackgroundGastric intestinal metaplasia is a common pathological feature in patients with Helicobacter pylori (H. pylori) infection. Rabeprazole was widely used as the first-line regimen for H. pylori infectious treatment. The objective of this study is to explore the mechanism of rabeprazole in gas...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jing Xie, Xinhua Liang, Fangfang Xie, Canxin Huang, Zijun Lin, Shuping Xie, Fangying Yang, Fengfeng Zheng, Lanlan Geng, Wanfu Xu, Sitang Gong, Li Xiang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-11-01
coleção:	Frontiers in Pharmacology
Assuntos:	H. pylori gastric intestinal metaplasia rabeprazole ferroptosis CREB
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1409001/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!